BODEN: So I talked with Scott Brunner about this
Current evidence does not support routine clinical use of GLP-1 medications specifically for alcohol cravings, and patients with alcohol use disorder should be referred to evidence-based treatments including behavioral interventions, mutual support groups, and FDA-approved pharmacotherapies such as naltrexone, acamprosate, and disulfiram
Direct activation of sexual desire centers in the brain Works in both men and women , regardless of age or hormonal status Non-hormonal, non-anabolic, and non-stimulant Enhances natural sexual experience, confidence, and arousal response Effective even when traditional therapies fall short Summary PT-141 (Bremelanotide) 20 mg Vial offers a revolutionary approach to sexual dysfunction treatment and libido enhancement , especially in cases where traditional medications are ineffective
References DiCiaula, A., Wang, D.Q.H., Portincasa, P